SINT
Sintx Technologies, Inc. [SINT] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
SINT Stock Summary
Top 10 Correlated Stocks
SINT
In the News
SINT Financial details
Company Rating
-
Market Cap
2.91M
Income
-5M
Revenue
2.06M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
43
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
-0.15
Forward P/E
-
PEG
0.02
P/S
1.17
P/B
0.15
P/C
-
P/FCF
-0.12
Quick Ratio
1.71
Current Ratio
2.09
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.58
EPS next Y
-
EPS next Q
-
EPS this Y
-95.96%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-62.83%
Revenue last 5Y
30.69%
Revenue Q/Q
33.04%
EPS Q/Q
-30.26%
-
-
-
-
SMA20
-25%
SMA50
-
SMA100
-40%
Inst Own
-
Inst Trans
-
ROA
-71%
ROE
-96%
ROC
-1.15%
Gross Margin
74%
Oper. Margin
-965%
Profit Margin
-792%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.022-2.19
52W High
-
52W Low
-
RSI
35
Rel Volume
-
Avg Volume
8.43M
Volume
36.02K
Perf Week
-10.08%
Perf Month
-10.08%
Perf Quarter
11.07%
Perf Half Y
15.47%
-
-
-
-
Beta
1.421
-
-
Volatility
0.11%, 0.17%
Prev Close
-3.31%
Price
3.21
Change
-5.59%
Company Profile
- Volume Average 8.43M
- Market Capitalization 2.91M
- Employee 43
- CEO Dr. B. Sonny Bal J.D., M.B.A., M.D., Ph.D.
- Headquarters Salt Lake City,UT,US
- IPO Date 2014-02-13
-
Website
https://www.sintx.com 
Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
